![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|
|
Monica Ramirez Basco, PhD |
|
|
|
David Miklowitz, PhD |
Holly A. Swartz, MD |
The MDQ is a screening tool for bipolar spectrum disorders and takes about 5 minutes to complete. The MDQ assesses symptoms of mania and hypomania based on the DSM-IV criteria for bipolar disorder. Any positive screening should be followed up with a comprehensive clinical assessment. | The BSDS is designed to be sensitive to the milder variants of bipolar disorder. The scale is helpful for screening for bipolar disorder, but there is limited evidence that it can be used to monitor treatment progress. It is more helpful in ruling out a diagnosis of bipolar disorder than making a diagnosis. | The PHQ-9 is a widely used screening tool that can help both in identifying individuals with major depression disorder as well as assessing the severity of depressive symptoms. | The GAD-7 is used to screen for the presence of anxiety. It can be used to monitor severity of anxiety symptoms over time and has been found to be sensitive to change. |
![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() |
![]() |
Aimee Sullivan, PhD
|
![]() |
|
![]() | ![]() | ![]() |
New Mood Disorder Intensive Outpatient Program Opening 11/4/2024!